Drug profile · INN
entacapone
COMTAN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
entacapone (COMTAN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN entacapone
Brand COMTAN
Route ORAL
Formulation TABLET
ATC code N04BX02
Originator Teva Pharma GmbH
Frequently asked questions
What is entacapone?
entacapone (COMTAN) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for entacapone?
COMTAN is a marketed brand name for entacapone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of entacapone?
entacapone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.